Obat antiretroviral: Perbedaan antara revisi

Konten dihapus Konten ditambahkan
Kenrick95Bot (bicara | kontrib)
k Bot: perubahan kosmetika !
Muhammad Anas Sidik (bicara | kontrib)
Tidak ada ringkasan suntingan
Tag: Suntingan perangkat seluler Suntingan peramban seluler Suntingan seluler lanjutan
 
(20 revisi perantara oleh 15 pengguna tidak ditampilkan)
Baris 1: Baris 1:
'''Obat antiretroviral''' adalah pengobatan untuk perawatan infeksi oleh [[retrovirus]], terutama [[HIV]]. Kelas obat antiretroviral yang berbeda berjaman pada stadium lingkaran kehidupan HIV yang berbeda. Kombinasi beberapa obat antiretroviral diketahui sebagai '''''terapi antiretroviral yang sangat aktif''''' ('''''HAART''''').
'''Obat antiretroviral''' adalah pengobatan untuk perawatan infeksi oleh [[retrovirus]], terutama [[HIV]]. Kelas obat antiretroviral yang berbeda berjaman pada stadium lingkaran kehidupan HIV yang berbeda. Kombinasi beberapa obat antiretroviral diketahui sebagai '''''terapi antiretroviral yang sangat aktif''''' ('''''HAART''''').


Organisasi seperti [[National Institutes of Health]] [[Amerika Serikat]] merekomendasikan penawaran perawatan antiretroviral untuk semua pasien dengan [[AIDS]], tetapi, karena kerumitan untuk memilih dan mengikuti sebuah aturan, adanya efek samping, dan kepentingan untuk mencegah virus melawan perawatan ini, organisasi seperti itu menekankan kepentingan pilihan pasien yang ikut serta dalam terapi dan merekomendasikan menganalisis risiko dan potensi terhadap pasien tanpa gejala.<ref name="2002nihguidelines">{{cite web | url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=retrieve&db=pubmed&list_uids=12617573&dopt=Abstract | title=Guidelines for using antiretroviral agents among HIV-infected adults and adolescents | accessdate=2006-01-09 | year=[[2002-09-03]] | author=Panel on Clinical Practices for Treatment of HIV | publisher=PubMed and National Institutes of Health}}</ref>
Organisasi seperti [[National Institutes of Health]] [[Amerika Serikat]] merekomendasikan penawaran perawatan antiretroviral untuk semua [[pasien]] dengan [[AIDS]], tetapi, karena kerumitan untuk memilih dan mengikuti sebuah aturan, adanya [[efek samping]], dan kepentingan untuk mencegah virus melawan perawatan ini, organisasi seperti itu menekankan kepentingan pilihan pasien yang ikut serta dalam terapi dan merekomendasikan menganalisis risiko dan potensi terhadap pasien tanpa gejala.<ref name="2002nihguidelines">{{cite web | url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=retrieve&db=pubmed&list_uids=12617573&dopt=Abstract | title=Guidelines for using antiretroviral agents among HIV-infected adults and adolescents | accessdate=2006-01-09 | year=2002-09-03 | author=Panel on Clinical Practices for Treatment of HIV | publisher=PubMed and National Institutes of Health}}</ref>


== Catatan kaki ==
== Catatan kaki ==
Baris 7: Baris 7:


== Pranala luar ==
== Pranala luar ==
* [http://www.aidsmeds.com/lessons/DrugChart.htm Drug Chart]
* [http://www.aidsmeds.com/list.shtml Drug Chart]
* [http://www.aidsmeds.com/ Further drug information]
* [http://www.aidsmeds.com/ Further drug information]
* [http://www.AIDSinfo.nih.gov/ NIH web site]
* [http://www.AIDSinfo.nih.gov/ NIH web site] {{Webarchive|url=https://web.archive.org/web/20210322035857/https://aidsinfo.nih.gov/ |date=2021-03-22 }}
* [http://www.aidsinfonyc.org/tag/tx/saquinavirten.html Ten Texts on Saquinavir]
* [http://www.aidsinfonyc.org/tag/tx/saquinavirten.html Ten Texts on Saquinavir] {{Webarchive|url=https://web.archive.org/web/20060214020555/http://www.aidsinfonyc.org/tag/tx/saquinavirten.html |date=2006-02-14 }}
* [http://www.retroconference.org/2000/abstracts/509.htm The Synergistic Inhibition of HIV-1 With Nucleoside Analogs Combined With A Natural Product, Resveratrol]
* [http://www.retroconference.org/2000/abstracts/509.htm The Synergistic Inhibition of HIV-1 With Nucleoside Analogs Combined With A Natural Product, Resveratrol] {{Webarchive|url=https://web.archive.org/web/20060221184321/http://www.retroconference.org/2000/abstracts/509.htm |date=2006-02-21 }}
* [http://www.aidsmap.com/news/newsdisplay2.asp?newsId=2161 AZT resistance may be reversed by rheumatic drug]
* [http://www.aidsmap.com/news/newsdisplay2.asp?newsId=2161 AZT resistance may be reversed by rheumatic drug] {{Webarchive|url=https://web.archive.org/web/20040702083640/http://www.aidsmap.com/news/newsdisplay2.asp?newsId=2161 |date=2004-07-02 }}
* [http://www.inviraseinfo.com Saquinavir Mesylate - Invirase (warning: commercial product web page)]
* [http://www.inviraseinfo.com Saquinavir Mesylate - Invirase (warning: commercial product web page)] {{Webarchive|url=https://web.archive.org/web/20170703211615/http://www.inviraseinfo.com/ |date=2017-07-03 }}
* [http://www.aegis.com/pubs/atn/1993/ATN17001.html Origins of antiretroviral combination therapy]
* [http://www.aegis.com/pubs/atn/1993/ATN17001.html Origins of antiretroviral combination therapy] {{Webarchive|url=https://web.archive.org/web/20040118031924/http://www.aegis.com/pubs/atn/1993/ATN17001.html |date=2004-01-18 }}
* [http://www.cptech.org/ip/health/aids/druginfo.html] Drug Patent Expiration Info
* [http://www.cptech.org/ip/health/aids/druginfo.html] Drug Patent Expiration Info
* [http://www.sciencedaily.com/releases/2007/07/070723160034.htm
* [http://www.sciencedaily.com/releases/2007/07/070723160034.htm]
* [http://d4t.info Information on D4t , stavudine, zerit - AIDS medicine]
* [http://d4t.info Information on D4t, stavudine, zerit - AIDS medicine] {{Webarchive|url=https://web.archive.org/web/20071017175646/http://d4t.info/ |date=2007-10-17 }}
* [http://www.acria.org/treatment/treatment_edu_summerupdate2005.html Effects of HIV Drugs on the body]
* [http://www.acria.org/treatment/treatment_edu_summerupdate2005.html Effects of HIV Drugs on the body] {{Webarchive|url=https://web.archive.org/web/20070929133702/http://www.acria.org/treatment/treatment_edu_summerupdate2005.html |date=2007-09-29 }}
* [http://www.thebody.com/vltest.html Viral Load] research papers, including effectiveness of HAART on reducing viral load
* [http://www.thebody.com/vltest.html Viral Load] research papers, including effectiveness of HAART on reducing viral load


[[Kategori:Obat antiretroviral| ]]
{{medis-stub}}

[[Kategori:AIDS]]
[[Kategori:AIDS]]
[[Kategori:Obat antiretroviral| ]]
[[Kategori:Obat]]
[[Kategori:Obat antivirus]]


{{medis-stub}}
[[de:Hochaktive antiretrovirale Therapie]]
[[en:Antiretroviral drug]]
[[es:Antirretroviral]]
[[fi:Antiretroviraalit]]
[[fr:Antirétroviral]]
[[ja:HAART療法]]
[[no:Antiretrovirale medisiner]]
[[pl:HAART]]
[[ru:Высокоактивная антиретровирусная терапия]]
[[sv:Antiretrovirala läkemedel]]
[[zh:抗反轉錄病毒藥物]]